Keytruda Archives - Express Pharma

Cipla partners with Qilu Pharmaceutical for licensing and supply of biosimilar to Keytruda in US

Merck’s colorectal cancer therapy fails late-stage trial

Merck discontinues Phase 3 trial for lung cancer combo drug

FDA approved KEYTRUDA in combination with chemotherapy for adult patients with endometrial carcinoma

Merck discontinues Phase 3 KeyVibe-010 trial

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma

DCGI approves MSD India’s Keytruda for treating cervical and esophageal cancers

Amgen says Lumakras plus immunotherapy for lung cancer needs further study

Pfizer and BioNTech’s COVID-19 vaccine Comirnaty tops the list of best-selling drugs